10-Q Filing

UNI-PIXEL CIK: 1171012 Q3 2011

Filing Information

Form Type	10-Q
Accession Number	`0001185185-11-001895`
Period End Date	20110930
Filing Date	20111110
Fiscal Year	2011
Fiscal Period	Q3
XBRL Instance	unxl-20110930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 44 Income Statement 52 Cash Flow Statement 43 Stockholders Equity 19

Balance Sheet 44 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.54M	USD	Point-in-time
Accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.85M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.49M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$307.85K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$972.61K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.05M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$48.00	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$77.89K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.49M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	7.14M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$13.13M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	7.13M	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $1,849,314 and $1,543,839, at September 30, 2011 and December 31, 2010, respectively	`PropertyPlantAndEquipmentNet`	$1.20M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $1,849,314 and $1,543,839, at September 30, 2011 and December 31, 2010, respectively	`PropertyPlantAndEquipmentNet`	$70.73K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	7.14M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	7.13M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$17.44K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$17.44K	USD	Point-in-time
Total assets	`Assets`	$13.22M	USD	Point-in-time
Total assets	`Assets`	$9.72M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$143.60K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$341.54K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$85.91K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$143.60K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$427.45K	USD	Point-in-time
Total liabilities	`Liabilities`	$427.45K	USD	Point-in-time
Total liabilities	`Liabilities`	$143.60K	USD	Point-in-time
Commitments and contingencies (Note 3)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 3)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized, 7,142,307 shares issued and outstanding at September 30, 2011 and 7,131,890 shares issued and outstanding at December 31, 2010	`CommonStockValue`	$7.13K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized, 7,142,307 shares issued and outstanding at September 30, 2011 and 7,131,890 shares issued and outstanding at December 31, 2010	`CommonStockValue`	$7.14K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$69.99M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$66.51M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-60.42M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-53.73M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$-2.13M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$9.57M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$12.79M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$9.72M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$13.22M	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
Revenue	`SalesRevenueNet`	$190.30K	USD	3 Qtrs
Revenue	`SalesRevenueNet`	$731.00	USD	1 Quarter
Revenue	`SalesRevenueNet`	$140.04K	USD	3 Qtrs
Revenue	`SalesRevenueNet`	$37.27K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$1.07K	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	$440.00	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$44.45K	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	$1.07K	USD	1 Quarter
Gross margin	`GrossProfit`	$138.96K	USD	3 Qtrs
Gross margin	`GrossProfit`	$291.00	USD	1 Quarter
Gross margin	`GrossProfit`	$36.20K	USD	1 Quarter
Gross margin	`GrossProfit`	$145.85K	USD	3 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$3.29M	USD	3 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.29M	USD	3 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$845.67K	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$580.37K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.03M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.21M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.56M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$719.59K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.36M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-1.88M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-6.70M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-1.26M	USD	1 Quarter
Gain on sale of intellectual property	`GainLossOnDispositionOfIntangibleAssets`	$2.09M	USD	3 Qtrs
Debt issuance expense	`DebtRelatedCommitmentFeesAndDebtIssuanceCosts`	$461.95K	USD	3 Qtrs
Debt issuance expense	`DebtRelatedCommitmentFeesAndDebtIssuanceCosts`	$139.90K	USD	1 Quarter
Interest income (expense), net	`InterestExpense`	$219.28K	USD	3 Qtrs
Interest income (expense), net	`InterestExpense`	$-10.08K	USD	3 Qtrs
Interest income (expense), net	`InterestExpense`	$-2.64K	USD	1 Quarter
Interest income (expense), net	`InterestExpense`	$74.99K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.82M	USD	Annual
Net loss	`NetIncomeLoss`	$-6.69M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.48M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.95M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.87M	USD	1 Quarter
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.85	USD	3 Qtrs
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.94	USD	3 Qtrs
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.26	USD	1 Quarter
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.43	USD	1 Quarter
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.43	USD	1 Quarter
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.94	USD	3 Qtrs
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.26	USD	1 Quarter
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.85	USD	3 Qtrs
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.14M	shares	3 Qtrs
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.14M	shares	1 Quarter
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	3.47M	shares	1 Quarter
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	3.47M	shares	3 Qtrs
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.14M	shares	3 Qtrs
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.14M	shares	1 Quarter
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	3.47M	shares	1 Quarter
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	3.47M	shares	3 Qtrs

Cash Flow Statement 43 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.82M	USD	Annual
Net loss	`NetIncomeLoss`	$-6.69M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.48M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.95M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.87M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$182.74K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$305.47K	USD	3 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$3.41M	USD	3 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$2.35M	USD	Annual
Stock compensation expense	`ShareBasedCompensation`	$2.12M	USD	3 Qtrs
Amortization of deferred loan costs	`AmortizationOfFinancingCosts`	$461.95K	USD	3 Qtrs
Bad debt expense	`ProvisionForDoubtfulAccounts`	$33.77K	USD	3 Qtrs
Amortization of discounts on notes payable	`AmortizationOfDebtDiscountPremium`	$46.24K	USD	3 Qtrs
Gain on sale of intellectual property	`GainLossOnDispositionOfIntangibleAssets`	$2.09M	USD	3 Qtrs
(Increase) decrease in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-53.25K	USD	3 Qtrs
(Increase) decrease in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$44.07K	USD	3 Qtrs
Decrease in accounts payable	`IncreaseDecreaseInAccountsPayable`	$-197.94K	USD	3 Qtrs
Decrease in accounts payable	`IncreaseDecreaseInAccountsPayable`	$-143.87K	USD	3 Qtrs
Increase in accrued interest payable	`IncreaseDecreaseInInterestPayableNet`	$174.88K	USD	3 Qtrs
Decrease in deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-85.91K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.25M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.19M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.44M	USD	3 Qtrs
Proceeds from the sale of intellectual property	`ProceedsFromSaleOfIntangibleAssets`	$2.25M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.44M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.25M	USD	3 Qtrs
Proceeds from convertible notes payable	`ProceedsFromConvertibleDebt`	$775.00K	USD	3 Qtrs
Payment of deferred loan costs	`PaymentsOfDebtIssuanceCosts`	$108.73K	USD	3 Qtrs
Proceeds from exercise of stock options, net	`ProceedsFromStockOptionsExercised`	$73.14K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$666.27K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$73.14K	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$664.76K	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-4.55M	USD	3 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$8.49M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$307.85K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$972.61K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$13.05M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$8.49M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$307.85K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$972.61K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$13.05M	USD	Point-in-time
Issuance of warrants to convertible note investors	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$12.01K	USD	3 Qtrs
Issuance of warrants to Placement Agent	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$60.55K	USD	3 Qtrs

Stockholders Equity 19 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-2.13M	USD	Point-in-time
Balance	`StockholdersEquity`	$9.57M	USD	Point-in-time
Balance	`StockholdersEquity`	$12.79M	USD	Point-in-time
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$15.28M	USD	Annual
Conversion of debt and accrued interest into common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.04M	USD	Annual
Stock compensation expense	`ShareBasedCompensation`	$2.12M	USD	3 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$3.41M	USD	3 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$2.35M	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$73.14K	USD	3 Qtrs
Issuance of warrants to convertible note investors	`AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt`	$12.01K	USD	Annual
Issuance of warrants to placement agent	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$60.55K	USD	Annual
Net loss	`NetIncomeLoss`	$-3.82M	USD	Annual
Net loss	`NetIncomeLoss`	$-6.69M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.48M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.95M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.87M	USD	1 Quarter
Balance	`StockholdersEquity`	$-2.13M	USD	Point-in-time
Balance	`StockholdersEquity`	$9.57M	USD	Point-in-time
Balance	`StockholdersEquity`	$12.79M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.